Go Beyond Biomarkers
to a Functional Assessment
of Individual Patient Response
Live human tumor tissue fully preserved in fluidic microenvironments for ex vivo drug testing combined with the power of cloud analytics platform accelerates successful clinical trials.
Too Many Oncology Drug
Therapies Fail in Clinical Trials
In vivo testing of engineered mice are notoriously poor predictors of human response. Add to that, vast amounts of overwhelming and scattered data that sits un-analyzed on hard drives. The result is: Drug after drug fails to pass FDA approval for lack of understanding.
It’s Time to Accelerate
Successful Clinical Trials
Gain rapid understanding of drug mechanisms for novel drug therapies with a powerful combination of live human tissue biology and cloud computing. Your therapies are tested in an ex vivo system that uses biopsies of patient tumors, preserving the tumor microenvironment unique to that patient.
Response data is captured and rapidly integrated in a cloud analytics platform to inform every step of your drug development process.
Meet The Xshpera Biology + Cloud Platform
for Accelerated Drug Development
Drug Study
Planning
Plan all the parameters of your study with our experienced team.
Live Human
Tissue
Test on live human tumor tissue sourced from our international provider network.
AI-Driven Study Results
Unlock the complexity of each patient’s response with AI-driven analytics.
On-Demand Interrogation
Use real-time evidence to make informed decisions and adjust your drug or study.
Unleash new levels of understanding
Capture patient variability
for drug response
More successful drug development means better speed to market for the patient impact you’re looking for.
Licensed Dana Farber Technology.
Now Serving the Top Pharma Companies
Xshpera Bioscience works with more than XX top
pharma companies in the US.
View Case Studies
Ready to Learn More?
© 2023 Xsphera Biosciences
6 Tide Street
Boston, MA, 02210 — ALL RIGHTS RESERVED